2.4. Outcomes
gastrointestinal manifestations, diarrhea, abdominal pain, vomiting, COVID-19 infection, anorexia
ANOREXIA, COVID-19 INFECTION
The main outcomes were the assessment of risk factors associated with mortality to determine whether use of the food supplement had a positive effect. These outcomes were (1) reduction in the average duration (days) of persistent digestive symptoms in the patients with gastrointestinal manifestations (measured according to history at admission of at least one of these symptoms: diarrhea, vomiting, abdominal pain or anorexia) and (2) reduction in length of hospital stay (days from admission until discharge) in the patients admitted with COVID-19 infection with normal–mild–moderate chest X-ray severity. Comparisons were made between the group of patients receiving Gasteel Plus